Then, we aimed to enhance the understanding of radiomic features associated with KRAS and EGFR mutations in lung adenocarcinoma and to evaluate the effectiveness of the features in accurately classifying mutations. The gene discussed is KRAS; the disease is lung adenocarcinoma.